Antizol
NDC Package 46129-200-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Antizol is ® is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis (see DOSAGE AND ADMINISTRATION). Marketed by Paladin Laboratories (usa) Inc, this product is identified by NDC 46129-200 and is authorized under FDA application NDA020696.

Identification & Billing

NDC Package Code
46129-200-01
Package Description
1 VIAL in 1 PACKAGE / 1.5 mL in 1 VIAL
Product Code
46129-200
11-Digit Billing Format
46129020001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Antizol
Dosage Form
-
Usage Information
Antizol® is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis (see DOSAGE AND ADMINISTRATION).

Regulatory & Marketing

Labeler Name
Paladin Laboratories (usa) Inc
FDA Application #
NDA020696
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-31-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (46129-200). Click a package code to view its specific billing and regulatory data.

46129-200-02
4 VIAL in 1 PACKAGE / 1.5 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46129-200-01 identifies a specific commercial package of 1 vial in 1 package / 1.5 ml in 1 vial of Antizol, labeled by Paladin Laboratories (usa) Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Paladin Laboratories (usa) Inc on July 31, 2009. The current certification is valid through December 31, 2017.

How is this Paladin Laboratories (usa) Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46129020001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
46129-200-01
11-Digit CMS (5-4-2)
46129-0200-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.